Author

E P Panchenko

Observed name: EP Panchenko

Institution: National Medical Research Center of Cardiology

Observed institution: National Medical Research Center of Cardiology

OpenAlex ID: A5066364508

[Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].

2000 · A V Semenov, M Ia Kogan-Ponomarev, et al. · PubMed · 22

[Results of three year observation of outpatients with clinical manifestations of atherothrombosis (analysis of Russian population of REACH registry)].

2009 · E P Panchenko · PubMed · 15

[Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].

2011 · N M Vorob'eva, E P Panchenko, et al. · PubMed · 10

[Matrix metalloproteinases, C-reactive protein, and markers of thrombinemia in patients with stable angina and restenoses after percutaneous coronary interventions.].

2004 · O A Zemlianskaia, E P Panchenko, et al. · PubMed · 9

[Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease].

2011 · A L Komarov, E P Panchenko, et al. · PubMed · 5

[CYP2C9 and VKORC1 gene polymorphism and acenocoumarol anticoagulant activity in Russian patients at high risk of thromboembolic complications].

2011 · D A Sychev, I V Ignat'ev, et al. · PubMed · 4

[Pharmacogenetics of indirect anticoagulants: value of genotype for improvement of efficacy and safety of therapy].

2006 · D A Sychov, E S Kropacheva, et al. · PubMed · 4

[Independent predictors of deep vein thrombosis (results of prospective 18 months study)].

2010 · N M Vorob'eva, E P Panchenko, et al. · PubMed · 3

[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation].

2007 · D A Sychev, Iu A Mikheeva, et al. · PubMed · 3

[Incidence Rate of Various Vascular Beds Impairment and Pharmacological Treatment of Patients at High Risk of Atherothrombotic Complications. Russian Results of International Trial AGATHA.].

2004 · A L Komarov, E P Panchenko · PubMed · 3

[Factors determining prognosis of patients with stable ischemic heart disease (results of a five years prospective study)].

2012 · A L Komarov, O O Shakhmatova, et al. · PubMed · 2

[Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins].

2011 · N M Vorob'eva, E P Panchenko, et al. · PubMed · 2

[Risk factors for venous thromboembolic complications and their association with D-dimer level].

2010 · N M Vorob'eva, E P Panchenko, et al. · PubMed · 2

[Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].

2005 · E S Kropacheva, E P Panchenko, et al. · PubMed · 2

[Long-term therapy with anticoagulants in patients with nonvalvular atrial fibrillation (prospective follow-up). Part I. Effect of 12-month therapy with acenocoumarol on content of d-dimer, frequency of thrombosis and parameters of hemodynamics of left auricle].

2004 · E S Kropacheva, E P Panchenko, et al. · PubMed · 2

[Plasminogen activator inhibitor and protein C: their relation to plasma lipids and lipo- and apoproteins in ischemic heart disease of different duration].

1990 · D A Zateĭshchikov, N A Gratsianskiĭ, et al. · PubMed · 2

Peripheral atherosclerosis and abdominal aortic aneurysm as a new risk factors of upper gastrointestinal bleeding in patients with stable CAD receiving long-term antithrombotic therapy

2021 · V Korobkova, AL Komarov, et al. · European Journal of Preventive Cardiology · 1

PDF

[Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study].

2010 · D A Sychev, I M Antonov, et al. · PubMed · 1

[Role of D-dimer in diagnosis of venous thrombosis and embolism].

2001 · E S Kropacheva, E V Titaeva, et al. · PubMed · 1

[Antithrombotic therapy in acute coronary syndrome].

2000 · E I Chazov, E P Panchenko · PubMed · 1

[Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].

1997 · E P Panchenko · PubMed · 1

[The effect of long-term Fraxiparin treatment on hemostasis in patients with primary pulmonary hypertension].

1997 · I E Chazova, E P Panchenko, et al. · PubMed · 1

[Newly developed stenocardia: effect of intensive physical training on the indicators of the blood coagulation system and fibrinolysis].

1991 · A V Karasev, L V Liutova, et al. · PubMed · 1

[Fibronectin and its clinical significance].

1987 · Iu B Belousov, A V Shishkin, et al. · PubMed · 1

[Phosphocreatine: thrombocyte aggregation in patients with stenocardia].

1987 · E P Panchenko, S V Shalaev, et al. · PubMed · 1

Works count: 68

Citation count: 99

H-index: 5

I10-index: 3